Xigui Chen
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
PQBP1-dependent alternative RNA splicing underlies high calorie diet-induced cognitive impairment.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Intestinal CD4-CD8αβ-TCRαβ+ T cells function as tolerogenic antigen presenting cells in mice.
Journal: Nature communications
Published: July 30, 2023
Methods to Image Macroautophagy in the Brain In Vivo.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 06, 2019
Chronic cerebral hypoperfusion shifts the equilibrium of amyloid β oligomers to aggregation-prone species with higher molecular weight.
Journal: Scientific reports
Published: September 28, 2018
The intellectual disability gene PQBP1 rescues Alzheimer's disease pathology.
Journal: Molecular psychiatry
Published: May 09, 2018
Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1.
Journal: Nature communications
Published: April 04, 2017
Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology.
Journal: Nature communications
Published: March 07, 2017
HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease.
Journal: Scientific reports
Published: June 15, 2016
Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathology.
Journal: Human molecular genetics
Published: June 07, 2016
Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical libraries.
Journal: Scientific reports
Published: June 01, 2016
RpA1 ameliorates symptoms of mutant ataxin-1 knock-in mice and enhances DNA damage repair.
Journal: Human molecular genetics
Published: March 28, 2016
Last Updated: 09/26/2026